Mycovia Pharmaceuticals, Inc.

Durham, NC

UEI
MFPUBFBD4ZX1
CAGE
7B9J7
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
4819 Emperor Blvd #400, Durham, NC 27703, USA
Website
mycovia.com
Founded
2018
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Mycovia Pharmaceuticals, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Optimized CYP51 inhibitors for the oral treatment of CNS coccidioides infections Grant · R33AI101497 National Institutes of Health $710,000

Contract vehicles

Mycovia Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Mycovia Pharmaceuticals, Inc.'s UEI?

Mycovia Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is MFPUBFBD4ZX1.

What is Mycovia Pharmaceuticals, Inc.'s CAGE code?

Mycovia Pharmaceuticals, Inc.'s CAGE code is 7B9J7.

What is Mycovia Pharmaceuticals, Inc.'s primary NAICS code?

Mycovia Pharmaceuticals, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Mycovia Pharmaceuticals, Inc. located?

Mycovia Pharmaceuticals, Inc.'s physical address in SAM.gov is 4819 Emperor Blvd #400, Durham, NC 27703, USA.

Is Mycovia Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Mycovia Pharmaceuticals, Inc.'s SAM.gov registration is active through January 23, 2027.

Which contract vehicles does Mycovia Pharmaceuticals, Inc. hold?

Mycovia Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Mycovia Pharmaceuticals, Inc.'s most recent federal award?

Mycovia Pharmaceuticals, Inc.'s most recent federal grant award is Optimized CYP51 inhibitors for the oral treatment of CNS coccidioides infections (R33AI101497), from National Institutes of Health, on June 20, 2014.

On GovTribe

See Mycovia Pharmaceuticals, Inc.'s full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login